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Introduction
Catheter-based intracardiac interventions to treat a variety of intracardiac and vascular defects have become the preferred approach for many lesions. The variety of devices that can be delivered via peripheral vessel access into the cardiac chambers has increased over the years due largely to improved manufacturing technology. However, there are interventional tools and devices that are difficult to deliver due their size and complexity; and damage to peripheral blood vessels by the large size catheters has been reported [1] . Moreover, with a transcatheter peripheral approach, there is limited precision for device positioning and manipulation inside the beating heart due to the moving structures and catheter tip control from the long distance. These limitations have lead surgeons to develop transcardiac approaches for intracardiac procedures. Thus, transcardiac beating-heart surgical techniques that avoid use of cardio-pulmonary bypass (CPB) have evolved rapidly over the past decade and now are becoming more widely applied [2] . In contrast with catheter-based interventions, transcardiac procedures have the advantage of providing a more direct route for device deployment or tissue manipulation, avoiding the often complex trajectory required for peripheral access, provide a more stable tool tip inside the beating heart, and are not as limited by the size constraints of peripheral vessels. Various devices can be introduced directly through the heart wall with echocardiographic, fluoroscopic or magnetic resonance imaging (MRI) guidance. For example, transapical left ventricular access is currently widely applied for aortic valve replacement, and is even proposed for evolving techniques for mitral valve repair, and closure of ventricular septal defects [3] [4] [5] [6] [7] .
With an impending growing complexity of the instruments and devices for transcardiac repair, we anticipate the need to introduce these instruments safely inside the beating heart, minimizing the risk of introduction of air emboli and minimizing blood loss. In addition, depending on the procedure, some surgical tools may need to be introduced into the cardiac chamber multiple times during a single procedure. Thus, having the ability for easy and safe instrument exchange is of potential benefit. The risk associated with the introduction of large air bubbles into the cardiac chamber has been associated with end organ injury, including stroke [8] .
The goal of our project was to develop and evaluate a universal transcardiac port (cardioport) that allows introduction of a variety of tools and facilitates multiple instrument insertions and exchanges, while prevents introduction of air into the cardiac chamber and bleeding during port placement and instrument exchanges.
Methods

Port design requirements and implementation
The key design requirements for the cardioport included: (1) provide direct access of surgical tools into any of the cardiac chambers from various angles; (2) prevent introduction of air emboli detectable by echocardiography into the heart; (3) minimal blood loss from the heart during port introduction and operation as well as during instrument introduction and exchanges; (4) minimal damage from the port to the heart wall and intracardiac structures; (5) optimal surgical ergonomics to allow one-hand operation; (6) compatibility with imaging modalities that are used for guidance during beating-heart procedures, i.e. ultrasound and fluoroscopy. These design requirements were incorporated into the components of the cardioport [9] .
The design consists of a port body (11mm in diameter) and a series of interchangeable sleeves that form the interface between the port and matching instrument (Figure 1 ). The tool sleeves are designed for a variety of surgical instruments (1-5 mm in diameter) and serve as adapters in order to standardize the mating interface between the inner surface of the cardioport body and the outer surface of each instrument. This design feature serves primarily to minimize the amount of air inside the port body around an instrument or device and, at the same time allow smooth instrument movement within the cardioport. To minimize blood loss, a compliant trileaflet valve was developed and placed at the intracardiac tip of the cardioport. On the proximal side of the port, a series of O-rings seal the space between the instrument, tool sleeve, and the body preventing blood loss and introduction of air.
An additional design feature that improves safety of the procedure is the ability to "visualize" the cardioport using ultrasound imaging with minimal distortion or creation of artifact in the ultrasound image [10] . This was implemented by manufacturing the port body and the sleeves out of Polyvinylidene Fluoride (PVDF), or "Kynar", which is compatible with the ultrasound beam since it does not lead to ultrasound reverberations and artifact. The advantage of this feature is that the risk of injury to nearby intracardiac structures is minimized if the cardioport can be imaged as it penetrates the cardiac wall and is positioned within the cardiac chamber.
Port operation
First, the port body with an obturator is inserted into the heart through a purse string suture. Then, a tool sleeve, selected for a particular instrument or device, is inserted into the port body. The instrument is inserted into the tool sleeve and pushed forward until the distal tip of the instrument has just reached the valve located at the distal end of the port body. Then, to remove air bubbles, an active fluid purging system is activated inside the instrument and the port (Video). The fluid inflow of the system is connected to the port body, and the outflow is connected to an instrument via Luer lock connection. Standard wall suction is applied at the outflow on the instrument and a fluid reservoir (heparinized saline) is connected to the inflow. When the system is activated, the suction is applied through and/or around the instrument via the tool sleeve. This induces rapid flow of saline from a reservoir through the gap between the port body and tool sleeve and through the instrument, in order to ensure complete de-airing. The valve at the end of the cardioport body prevents blood from entering the port while fluid is circulating. Complete purging of the port and instrument is completed in approximately 5 seconds. After purging, the instrument is inserted inside the heart and used for surgical manipulations. This maneuver is repeated each time an instrument or device is inserted into the heart. After procedure is completed, the cardioport is removed, and the purse string suture is tied in a standard manner.
Ex vivo testing
The repeatability tests were conducted in a water tank equipped with ultrasound imaging. Effectiveness of air bubble removal, sturdiness of the port components, surgical ergonomics and ease of port operation were evaluated. The port and presence of air bubbles were visualized by 2-dimensional (2D) and 3-dimensional (3D) echocardiography using the X4 matrix transducer on a SONOS 7500 system (Philips Healthcare, Andover, MA). A standard 9Fr introducer sheath (Arrow International, Reading, PA) was used as a control.
Animal trials
The experimental protocol was approved by the Children's Hospital Boston Institutional Animal Care and Use Committee. All animals received humane care in accordance with the 1996 Guide for the Care and Use of Laboratory Animals recommended by the U.S. National Institute of Health.
In Yorkshire pigs weighing 60-70 kg (n=5) beating-heart interventions such as atrial septal defect (ASD) closure, ventricular septal defect (VSD) closure and mitral valve (MV) repair were modeled, as previously described [7, 11, 12] . Briefly, animals were anesthetized by intramuscular injection of tiletamine/zolazepam (7 mg/kg) and xylazine (4 mg/kg) and intubated with a cuffed endotracheal tube and ventilated with a pressure control ventilator (Healthdyne 105; Healthdyne Technologies, Marietta, GA). Anesthesia was maintained with 2-3% isoflurane. A median sternotomy or left side thoracotomy was performed; a few stay sutures were placed on the pericardium to optimize access to the cardiac chambers. Epicardial 2D and 3D echocardiography was used for procedure imaging and air bubbles visualization with the X7-2 matrix transducer on an IE33 system (Philips Healthcare, Andover, MA). Purse-string sutures of 3-0 or 4-0 polypropylene were placed on the heart wall for the cardioport insertion into the each chamber. After intravenous heparin administration (100 U/kg), the port was introduced into both right and left atria and ventricles. Effectiveness of air removal, occurrence of bleeding during port and instrument manipulations and surgical ergonomics were tested. Introduction of the instruments through a conventional 9Fr sheath and through the port, both after prior flushing but without use of the fluid purging system, served as a control.
Results
Ex vivo testing
For each tool sleeve (n=3) we inserted the tool, purged it, and then imaged the tip of the port as the tool passed through the end valve. This was repeated 50 times for each sleeve. All the components of the port system were operable throughout the tests. No air bubbles were visualized by 2D and 3D ultrasound. In contrast, we detected air bubbles after every tool insertion when using the conventional introducer or the un-purged port system (Figure 2 ).
Large animal experiments
Five series of trials were performed. In the first experiment, the port was introduced into the left ventricle, and operational durability of the system was tested in the presence of blood, inside the high pressure chamber, without introduction of instruments. In all the subsequent experiments (N=4), the port was introduced into each of the four cardiac chambers, and instruments for beating-heart procedures were introduced (Figure 3) . We used the modified instruments that were previously developed for ASD and VSD patch closure and for MV repair [7, 11, 12] . In particular, our tissue anchor deployment device was modified by adding the features for fluid flushing through its shaft.
Air was completely removed in all the instrument insertions (6-10 trials per chamber) and 2D, and 3D ultrasound images showed no air emboli. In contrast, air emboli were detected in 40-85% of the cases of instruments insertion without use of the purge system (Figure 4 , video). Port operation exhibited excellent surgical ergonomics and one handed control and stabilization of the port was observed in all the animal trials. Instrument introduction and exchange was fast and smooth. The operator was able to reach all the desired intracardiac structures with the cardioport, without injury to the heart wall. No bleeding occurred in any of the cases throughout the procedure, during port placement, instruments introduction and exchanges, and port removal.
Cardioscopy Port
The cardioport can also be coupled to an imaging system such as a conventional optical telescope for direct visualization, or even an ultrasound crystal array for ultrasound imaging. Following our initial experience with cardioscopy-assisted beating-heart procedures [11] , we have designed a next generation cardioscopy port that combines the features of the current cardioport system with additional optical imaging ( Figure 5 ). The 14 mm cardioport was manufactured out of implantable grade polyetheretherketone (PEEK). The inner compartment of the port has an exchangeable transparent plastic bulb at the end. It houses standard 5 mm telescope for imaging. The bulbs with various geometries can be mounted on the tip of the port depending on the procedure. The outer working channel is 3 mm in diameter and is used for instrument access. The port was designed for particular set of instruments, which eliminated the need for tool sleeves. The valve and fluid purging systems were successfully adapted from the current cardioport.
Conclusions
With recent advancements in intracardiac devices and imaging technologies, a growing variety of instruments have been used inside the beating heart. This includes not only traditional stent-based devices but also more complex instruments such as graspers, staplers, and patch deployment systems [2] . Despite the growing number and complexity of procedures, there are few if any available universal cardioport systems that facilitate safe and effective instruments introduction and exchange.
Our group has previously reported the use of modified ports developed for other port-access procedures, such as thoracoscopic or laparoscopic surgery, and utilized them for intracardiac beating-heart image-guided interventions in an experimental setting [13] . After initial promising results, however we found that such ports were not optimal for the work requirements of beating-heart transcardiac interventions, primarily due to the risk of air embolism during instrument introduction. Similar findings have been reported by others. Downing et al. tested a 15mm custom designed port in beating-heart mitral valve repair, where the port was introduced into the left atrium. Although the port worked adequately allowing the procedure to be completed, air introduction was encountered in all six animals; it was minimal in two, mild in three, and moderate in one case [14] .
Other investigators have proposed a universal system for instrument introduction [15] . Guiraudon et al. developed the universal cardiac introducer made out of vascular graft material and assembled out of two components: an attachment cuff and an airlock chamber with up to four sleeves for introduction of various instruments and devices. The cuff is sutured to cardiac wall, and intracardiac access is controlled with a vascular clamp. Instrument access inside the sleeves is controlled with snares. The airlock chamber acts as an air bubble trap; with the sleeves positioned vertically well above the heart port access. A saline line is connected to the airlock chamber to assist with de-airing. This port system is characterized by significant size and complexity. In addition, it may be challenging to use such a design for access into the high pressure cardiac chambers, especially left ventricle.
The advantage of our system is that an active fluid purging system is utilized, which ensures complete elimination of air bubbles from the instrument shaft prior to its entry into the cardiac chamber. Furthermore, the valve system prevents bleeding during instrument introduction and exchanges and allows port placement into high pressure chambers from various angles, which may be necessary during image-guided beating-heart transcardiac procedures. When the fluid purging system is enabled, the pressure in the port body becomes less than the pressure in the cardiac chambers. The compliant tri-leaflet valve was designed to exploit this pressure differential in order to seal against blood loss. In fact, as the pressure differential increases the seal becomes even stronger due to the design of the compliant valve's shape. It should be noted that the internal volume of the port body was also minimized so as to prevent blood loss during tool insertion and operation when the trileaflet valve is open. Furthermore, the availability of different size instrument sleeves allows the use of most conventional instruments and novel devices to be introduced via the port. In addition, although the current cardioport diameter is large, it can be reduced substantially for introduction into higher pressure chambers such as the left ventricle, which will further reduce the size of the defect at the site of port introduction into the heart. Additional important functionality of the cardioport system is to incorporate optical imaging. Video-assisted cardioscopy using visible wavelength light provides detailed, highmagnification imaging of the tool and the target. However, use of visible wavelength light requires that blood be physically displaced between the optical window of the cardioport and the target structures. This results in a limited field of view. While the described procedures can be performed in the beating heart with the current system, use of infrared (IR) light may improve the field of view. Infrared light permits limited transmission through blood [16] , but the depth of field of the current IR systems is still less than 1-2 centimeters, making navigation through the cardiac structures difficult. An additional limitation of the current IR systems is that they have a relatively low frame rate due to image processing time required, which makes visualization of rapidly moving structures such as heart valves difficult. Some of these limitations may be overcome by re-designing the location of the IR light detector, which reduce light loss through the transmission fibers. If implemented, this may enable two-or multiple-port operation inside the beating heart. Moreover, it would open a possibility of designing multifunctional tools for beating-heart intracardiac interventions such as developed for gastroenterological procedures [17] . As for current procedures, we believe that the key to success in safe navigation inside the beating heart is still to use combined, or hybrid, imaging. Fluoroscopy provides a "big picture" view for navigation toward cardiac chambers and three-dimensional echocardiography can give surgeons superior large volume spatial orientation, whereas cardioscopy offers detailed, high magnification view of the tools as it interacts with the target structure.
In conclusion, we have developed a novel cardioport system for safe and easy introduction of surgical tools into all the cardiac chambers. Use of the port improves safety of beatingheart procedures and facilitates further development of more complex instruments and devices. This technology may be an enabling platform for intracardiac image-guided beating-heart surgery.
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The equipment and technology used in the study were purchased using academic funds. The authors had full control of the design of the study, methods used, outcome measurements, analysis of data, and production of the written report. Fully assembled cardioport. A, schematic drawing of the port that shows the key components of the fluid purging and the valve systems. B, actual port with one of the tool sleeves inserted. The inset depicts the tri-leaflet valve at the intracardiac tip of the cardioport. Water tank port testing under 3D echocardiography. A. After de-airing the port, no bubbles are present. B. Control -without de-airing the port, large bubbles are present. C. Control with an introducer sheath, multiple large bubbles are present. Blue dashed line -the cardioport; green dashed line-introducer sheath; red dotted circle -the air bubbles detected. Arrow demonstrates the direction of the instrument insertion. The port introduction into the left ventricle during 3D echocardiography-guided muscular VSD closure. A, the port body is inserted. B, the sleeve is being inserted. C, the port is fully assembled. D, E, the instrument, the anchor deployment device, is inserted into the port, system is flushed, and the instrument is introduced into the left ventricle. Intraoperative epicardial 3D echocardiography, A, VSD closure, cardioport is inserted through the apex of the left ventricle, and the active fluid purging system is utilized, no air bubbles are detected. B, ASD closure, standard introducer sheath is used after prior flushing, air bubble are detected. Blue dashed line -the cardioport; green dashed line -the introducer sheath; red dotted circle -the air bubbles detected. Arrow demonstrates the direction of the instrument insertion. RA -right atrium, LA -left atrium, RV -right ventricle, LV -left ventricle. Next generation cardioscopy port. A, schematic drawing of the port that shows exchangeable transparent plastic bulbs. B, actual port with the spherical bulb.
